NOE-105
- Generic Name
- NOE-105
Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
- First Posted Date
- 2024-03-18
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Noema Pharma AG
- Target Recruit Count
- 180
- Registration Number
- NCT06315751
- Locations
- πͺπΈ
Noema TTS-201 Site #15, Burgos, Spain
πͺπΈNoema TTS-201 Site #27, Madrid, Spain
πͺπΈNoema TTS-201 Site #17, Oviedo, Spain
A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Noema Pharma AG
- Target Recruit Count
- 75
- Registration Number
- NCT05583955
- Locations
- π¦πΊ
Noema Investigator site, Sydney, New South Wales, Australia
A Study to Evaluate The Effects of RO5545965 in Participants With Negative Symptoms of Schizophrenia Treated With Antipsychotics
- First Posted Date
- 2016-07-06
- Last Posted Date
- 2017-06-07
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 33
- Registration Number
- NCT02824055
- Locations
- πΊπΈ
CNS Network, Garden Grove, California, United States
πΊπΈSt Louis Clinical Trials, Saint Louis, Missouri, United States
πΊπΈParexel California Clinical Trials Medical Group, Glendale, California, United States
A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone
- First Posted Date
- 2013-12-24
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 32
- Registration Number
- NCT02019329
A PET Study With RO5545965 in Healthy Male Volunteers
- First Posted Date
- 2013-08-14
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 9
- Registration Number
- NCT01923025
A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO5545965 in Healthy Volunteers
- First Posted Date
- 2013-05-29
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 44
- Registration Number
- NCT01864226
A Study of Safety, Pharmacokinetics (Including Food Effect) And Pharmacodynamics of RO5545965 in Healthy Volunteers
- First Posted Date
- 2012-10-22
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 53
- Registration Number
- NCT01711801
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath